1: (ROOT (S (S (NP (NNS Children)) (VP (VBP Are) (PP (IN At) (NP (NN Risk))) (PP (IN For) (S (NP (JJ COVI-19Even) (NNS children)) (VP (MD can) (VP (VB face) (NP (NP (JJ severe) (NNS complications)) (CC and) (NP (NP (NN death)) (PP (IN from) (NP (CD COVI-19))))))))))) (, ,) (S (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (NNS children)) (VP (VBN admitted) (PP (IN to) (NP (JJ pediatric) (NNP ICU))))))) (VP (VBP have) (VP (VBN had) (NP (VBG underlying) (NNS conditions))))) (. .)))
2: (ROOT (S (PP (VBG According) (PP (IN to) (NP (DT this) (NN report)))) (NP (NP (NNS children)) (, ,) (NP (NNS teens)) (, ,) (CC and) (NP (JJ young) (NNS adults))) (VP (VBP are) (PP (IN at) (NP (NP (JJR greater) (NN risk)) (SBAR (IN than) (SBAR (WHNP (WP what)) (S (VP (VBD was) (ADVP (RB previously)) (VP (VBN thought)))))))) (PP (VBG according) (PP (IN to) (NP (DT a) (JJ recent) (NN study))))) (. .)))
3: (ROOT (SINV (`` `) (S (NP (DT The) (NN idea) (SBAR (IN that) (S (NP (NNP COVI-19)) (VP (VBZ is) (VP (VBG sparing) (PP (IN of) (NP (JJ young) (NNS people)))))))) (VP (VBZ is) (ADJP (RB just) (JJ false)))) (, ,) ('' ') (VP (VBD said)) (NP (NML (NN study) (NN coauthor)) (NNP Lawrence)) (. .)))
4: (ROOT (S (SBAR (IN While) (S (NP (NNS children)) (VP (VBP are) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB get) (ADJP (RB very) (JJ sick)))))) (SBAR (IN if) (S (NP (PRP they)) (VP (VBP have) (NP (NP (JJ other) (JJ chronic) (NNS conditions)) (, ,) (PP (VBG including) (NP (NN obesity)))))))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ important)) (S (VP (TO to) (VP (VB note) (SBAR (IN that) (S (NP (NP (NNS children)) (PP (IN without) (NP (JJ chronic) (NN illness)))) (VP (VBP are) (ADVP (RB also)) (PP (IN at) (NP (NN risk)))))))))) (. .)))
5: (ROOT (S (NP (NNS Parents)) (VP (VBP need) (S (VP (TO to) (VP (VB continue) (S (VP (TO to) (VP (VB take) (NP (DT the) (NN virus)) (ADVP (RB seriously))))))))) (. .) ('' ')))
6: (ROOT (S (S (NP (NP (DT A) (NN study)) (VP (VBN published) (PP (IN in) (NP (NNP JAMA) (NNP Pediatrics))))) (VP (VBZ is) (NP (NP (DT the) (JJ first)) (SBAR (S (VP (TO to) (VP (VB describe) (NP (NP (DT the) (NNS characteristics)) (PP (IN of) (NP (NP (ADJP (RB seriously) (JJ ill)) (CD COVI-19) (JJ pediatric) (NNS patients)) (PP (IN within) (NP (NNP North) (NNP America))))))))))))) (, ,) (S (NP (PRP it)) (VP (VBD followed) (NP (NP (NP (CD 48) (JJ young) (NNS children)) (CC and) (NP (NP (JJ young) (NNS adults)) (PP (IN between) (NP (NP (DT the) (NNS ages)) (PP (PP (IN of) (S (VP (VBG being) (ADJP (JJ newborn))))) (PP (IN to) (NP (NP (CD 21) (NNS years)) (PP (IN of) (NP (NN age)))))))))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN admitted) (PP (IN to) (NP (NP (JJ pediatric) (NNPS ICUs)) (PP (IN for) (NP (HYPH COVI-19))))) (PP (IN in) (NP (NNP Canada) (CC and) (NNP America))) (PP (IN during) (NP (NNP March) (CC and) (NNP April) (CD 2020)))))))))) (. .)))
7: (ROOT (S (NP (NP (QP (IN Over) (CD 80)) (NN %)) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VBD had) (NP (NP (VBG underlying) (NNS conditions)) (PP (JJ such) (IN as) (NP (NP (NN obesity)) (, ,) (NP (NN diabetes)) (, ,) (NP (JJ immune) (NN suppression)) (, ,) (NP (NNS seizures)) (, ,) (CC or) (NP (JJ chronic) (NN lung) (NN disease))))) (, ,) (PP (IN of) (NP (NP (DT those) (CD 40) (NN %)) (VP (VBD depended) (PP (IN on) (NP (JJ technological) (NN support))) (PP (IN due) (IN to) (NP (NP (JJ developmental) (NNS delays)) (CC or) (NP (JJ genetic) (NNS anomalies)))))))) (. .)))
8: (ROOT (S (S (NP (NP (QP (IN Over) (CD 20)) (NN %)) (PP (IN of) (NP (DT these) (JJ young) (NNS patients)))) (VP (VBD experienced) (NP (NP (NN failure)) (PP (IN of) (NP (QP (CD 2) (CC or) (JJR more)) (NNS organs) (NNS systems))) (PP (IN due) (IN to) (NP (CD COVI-19)))))) (, ,) (CC and) (S (NP (QP (RB nearly) (CD 40)) (NN %)) (VP (VBD required) (NP (CC either) (DT a) (NML (NML (NN breathing) (NN tube)) (CC or) (NML (NN ventilator)))))) (. .)))
9: (ROOT (S (S (NP (NP (QP (RB Nearly) (CD 33)) (NN %)) (PP (IN of) (NP (DT the) (NNS children)))) (VP (VBD were) (ADVP (RB still)) (VP (VBN hospitalized) (PP (JJ due) (PP (IN to) (NP (CD COVI-19)))) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (ADJP (VB follow) (RP up)) (NN period))))) (, ,) (PP (IN with) (S (S (NP (CD 3)) (ADVP (RB still)) (VP (VBG requiring) (NP (NN ventilator) (NN support)))) (CC and) (NP (NP (CD 1)) (PP (IN on) (NP (NN life) (NN support))))))))) (: ;) (CC and) (S (NP (NP (CD 2)) (PP (IN of) (NP (NP (DT the) (NNS children)) (VP (VBN admitted) (PP (IN during) (NP (DT the) (NML (CD 3) (NN week)) (NN study) (NN period))))))) (VP (VBD lost) (NP (NP (PRP$ their) (NN battle)) (PP (IN with) (NP (DT this) (NN disease)))))) (. .)))
10: (ROOT (SINV (`` `) (S (NP (DT This) (NN study)) (VP (VBZ provides) (NP (NP (DT a) (JJ baseline) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ early) (NN disease) (NN burden)) (PP (IN of) (NP (CD COVI-19))) (PP (IN in) (NP (JJ pediatric) (NNS patients)))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NNP Hariprem) (NNP Rajasekhar)) (, ,) (NP (NP (DT a) (JJ pediatric) (NN intensivist)) (VP (VBN involved) (PP (IN in) (S (VP (VBG conducting) (NP (DT the) (NN study)) (PP (IN at) (NP (NP (NP (NML (NNP Robert) (NNP Wood) (NNP Johnson)) (NNP Medical) (NNP School) (POS 's)) (NNP Department)) (PP (IN of) (NP (NNPS Pediatrics))))))))))) (. .) ('' ')))
11: (ROOT (S (NP (DT The) (NNS findings)) (VP (VBP confirm) (SBAR (SBAR (IN that) (S (NP (DT this) (VBG emerging) (NN disease)) (VP (VBD was) (ADVP (RB already)) (ADJP (JJ widespread)) (PP (IN in) (NP (NNP March)))))) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (RB universally) (JJ benign)) (PP (IN among) (NP (NNS children)))))))) (. .) ('' ')))
12: (ROOT (S (NP (NP (DT The) (NN hospital) (NNS outcomes)) (PP (PP (IN for) (NP (NNS children))) (PP (IN in) (NP (DT this) (NN study))))) (VP (VBD was) (NP (NP (NP (NML (CD .2) (NN %)) (NN mortality) (NN rate)) (PP (IN for) (NP (NP (NNP PICU) (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJR lower) (NN rate)) (PP (IN for) (NP (NP (NNS incidences)) (PP (IN of) (NP (JJ respiratory) (NN failure)))))))))) (, ,) (PP (VBN compared) (PP (IN to) (NP (NP (DT a) (VBN reported) (CD 62) (NN %)) (PP (IN among) (NP (NP (NNS adults)) (VP (VBN admitted) (PP (IN to) (NP (NNS ICUs))))))))))) (. .)))
13: (ROOT (S (NP (NP (NNS Physicians)) (PP (IN in) (NP (DT the) (NML (NNP New) (NNP York)) (NNP Metropolitan) (NN area)))) (VP (VBP are) (VP (VBG reporting) (S (VP (VBG seeing) (SBAR (WHNP (WP what)) (S (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (DT a) (JJ new) (ADJP (HYPH COVI-19) (VBN related)) (NN syndrome)) (PP (IN in) (NP (NNS children))))))))))))) (. .)))
14: (ROOT (S (`` `) (S (SBAR (IN Although) (S (NP (NP (PRP$ our) (NNS data) (NN collection)) (PP (IN for) (NP (DT this) (NN study)))) (VP (VBZ has) (VP (VBN ended))))) (, ,) (NP (PRP we)) (VP (VBP continue) (S (VP (TO to) (VP (VB develop) (NP (NP (NNS collaborations)) (PP (IN with) (NP (NP (NNS colleagues)) (PP (PP (IN in) (NP (PRP$ our) (NN region))) (CC and) (PP (IN across) (NP (DT the) (NN country))))))) (S (VP (TO to) (VP (VB try) (S (VP (TO to) (VP (VB understand) (NP (DT these) (ADJP (RBR more) (JJ severe)) (NNS complications))))))))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said) (, ,) (S (VP (VBG citing) (NP (NP (NNS concerns)) (PP (JJ such) (IN as) (NP (NP (NN heart) (NN failure)) (CC and) (NP (NP (NP (DT the) (NNP Kawasaki) (ADJP (NN diseas) (HYPH -) (JJ like)) (NN condition)) (VBN termed) (S (NP (JJ pediatric) (NML (JJ mult) (HYPH -) (NN system)) (JJ inflammatory) (NN syndrome)))) (PP (IN as) (NP (NNS examples)))))))))) (. .)))
